Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not
FDA Law Blog: Biosimilars
FEBRUARY 11, 2024
The wide range of assertions supporting or opposing Health and Human Services’ (“HHS’”) recommendation that the Drug Enforcement Administration (“DEA”) reschedule cannabis federally from schedule I to schedule III would lead an outsider to conclude that commenters are referring to different substances. Letter to U.S.
Let's personalize your content